Lota S. Zoth, CPA

Lota Zoth has served in senior financial roles in a variety of commercial-stage companies, including serving as MedImmune Inc.’s corporate controller from 2002 to 2004 and its chief financial officer from 2004 until its acquisition by AstraZeneca in 2007. Prior to joining MedImmune in 2002, Ms. Zoth served in financial executive roles at PSINet Inc., Sodexho Marriott Services, Inc., Marriott International and PepsiCo, Inc. Ms. Zoth began her career as an auditor at Ernst & Young, LLP and is a Certified Public Accountant. Ms. Zoth has extensive board experience, and currently serves on the boards of Lumos Pharma, Inc., 89Bio, Inc., and enGene Holdings, Inc.

Ms. Zoth holds a Bachelor of Business Administration in Accounting, summa cum laude, from Texas Tech University.